Doctor profile · Federal record

Dr. Christopher Arico, PA-C

Physician Assistant · Naperville, IL

  • NPI 1912195058
  • Accepts Medicare
  • 19 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2155 City Gate Ln
Naperville, IL 605637733
(630) 547-5040
fax (630) 305-0094
Mailing address
Po Box 713260
Chicago, IL 606771260

Credentials & registration

NPPES · NUCC
NPI registered
October 2007 — 19 yrs on file
Profile last updated
June 21, 2023
Year of graduation
2007 — 19 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Illinois #085.002993

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1912195058. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,574
Distinct HCPCS
10
Medicare allowed
$138,352
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 2,091 274 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 456 371 $80
17000 Destruction of precancer skin growth, 1 growth 399 312 $51
99214 Established patient office or other outpatient visit, 30-39 minutes 211 175 $113
17110 Destruction of skin growth, 1-14 growths 181 165 $100
17004 Destruction of precancer skin growth, 15 or more growths 62 53 $152
11102 Biopsy of related skin growth, first growth 60 56 $82
99203 New patient office or other outpatient visit, 30-44 minutes 43 43 $100
99204 New patient office or other outpatient visit, 45-59 minutes 33 33 $148
99212 Established patient office or other outpatient visit, 10-19 minutes 23 21 $50

In context: peer comparison

Among 26 peers in this city , average services per provider: 102. This provider delivers 35× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$95,563
Transactions
229
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 90 $45,320.83
Janssen Biotech, Inc. 66 $31,319.60
Arcutis Biotherapeutics, Inc. 29 $9,192.54
GENZYME CORPORATION 11 $3,558.63
Regeneron Healthcare Solutions, Inc. 7 $2,547.24
Dermavant Sciences, Inc. 9 $1,454.42
PFIZER INC. 1 $800.00
E.R. Squibb & Sons, L.L.C. 6 $624.59
LEO Pharma Inc. 3 $502.64
Novartis Pharmaceuticals Corporation 3 $152.78
SUN PHARMACEUTICAL INDUSTRIES INC. 1 $29.00
Lilly USA, LLC 1 $23.62
Janssen Scientific Affairs, LLC 1 $23.16
Paratek Pharmaceuticals, Inc. 1 $13.75

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$69,405
Travel and Lodging
$11,621
Consulting Fee
$10,249
Food and Beverage
$4,189
Education
$99

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
775
Patients
406
Total drug cost
$111,492
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 178 119 $2,120
Ketoconazole Generic 143 71 $4,283
Doxycycline Hyclate Generic 120 42 $4,397
Hydrocortisone Generic 72 41 $364
Clobetasol Propionate Generic 53 39 $3,828
Metronidazole Generic 33 28 $2,787
Gabapentin Generic 32 0 $277
Fluorouracil Generic 31 25 $3,938
Betamethasone Dipropionate Generic 26 14 $1,616
Mupirocin Generic 20 15 $206

Frequently asked questions

Auto-generated from federal data
What is Dr. Christopher Arico's medical specialty?
Dr. Christopher Arico practices Physician Assistant in Naperville, IL.
Where does Dr. Christopher Arico practice?
Dr. Christopher Arico practices at 2155 City Gate Ln, Naperville, IL 605637733. Office phone: 6305475040.
What is Dr. Christopher Arico's NPI?
Dr. Christopher Arico's National Provider Identifier (NPI) is 1912195058, issued by NPPES.
Does Dr. Christopher Arico accept Medicare assignment?
Yes. Dr. Christopher Arico accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Arico commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.